What is it about?

This review discusses the evidence informing the clinical strategy for using levothyroxine in women with subclinical hypothyroidism during pregnancy and those who are planning conception, focusing on the benefits and risks of treatment. We also consider issues related to the monitoring and duration of treatment.

Featured Image

Read the Original

This page is a summary of: Subclinical Hypothyroidism in Women Planning Conception and During Pregnancy: Who Should Be Treated and How?, Journal of the Endocrine Society, May 2018, Endocrine Society,
DOI: 10.1210/js.2018-00090.
You can read the full text:

Read

Contributors

The following have contributed to this page